| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Abeona Therapeutics Inc. (ABEO) has 9 insiders with recent SEC Form 4 filings, including 5 buys and 5 sells. ABEO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.43M | $8.03M | - | |
| CFO | 587.2K | $3.30M | - | |
| VP | 464.7K | $2.61M | - | |
| Dir | 145.4K | $816.6K | - | |
| Dir | 139.1K | $781.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 26, 2024 | Charles Faith L.50 | Director | Buy | 7,550 | $3.28 | $24,764.00 | +10.7% | +54.3% | +63.5% | |
| Apr 25, 2024 | Seshadri Vishwas80 | Chief Executive Officer | Buy | 10,000 | $3.20 | $32,000.00 | +1.9% | +58.3% | +67.1% | |
| Apr 25, 2024 | O'Malley Brendan M.85 | SVP, General Counsel | Buy | 8,600 | $3.24 | $27,864.00 | +4.8% | +58.3% | +67.1% | |
| Apr 25, 2024 | Vazzano Joseph Walter75 | Chief Financial Officer | Buy | 5,608 | $3.14 | $17,609.12 | +2.5% | +58.3% | +67.1% | |
| Feb 6, 2024 | Seshadri Vishwas80 | Chief Executive Officer | Buy | 20,000 | $4.39 | $87,800.00 | +3.9% | +11.2% | +36.7% | |
| Jan 17, 2024 | Alvino Mark51 | Director | Sell | 7,084 | $5.11 | $36,199.24 | -10.1% | +51.0% | +1.9% | |
| Sep 27, 2023 | Alland Leila82 | Director | Sell | 7,246 | $3.90 | $28,269.54 | -9.2% | +28.5% | +49.7% | |
| Sep 27, 2023 | Alvino Mark51 | Director | Sell | 6,316 | $3.91 | $24,723.98 | -8.3% | +28.5% | +49.7% | |
| Sep 27, 2023 | Amoroso Michael71 | Director | Sell | 5,508 | $3.91 | $21,542.34 | -4.8% | +28.5% | +49.7% | |
| Sep 27, 2023 | Charles Faith L.50 | Director | Sell | 8,330 | $4.91 | $40,923.62 | -10.5% | +28.5% | +49.7% |